To meet market demands for global trials, ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the opening of a full service central laboratory in Bangalore, India.
Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry, will launch its recently enhanced Quick To Clinic(SM) program at the 2008 AAPS Annual Conference in Atlanta, Georgia.
PPD, Inc. today announced that its board of directors declared a cash dividend for the fourth quarter of 2008 under its annual cash dividend policy.
ACORN a CRO focused on oncology, announced today that its third quarter had once again exceeded projections as the company continues to experience banner growth.
The Institute of Clinical Research (ICR) has announced a specialist insurance and professional indemnity deal exclusively for its members.
Pharmaceutical Profiles delivers critical ivPK data in early drug development.
Octagon Research, a provider of software and services to the life sciences industry, today announced the release of a global document authoring template suite.
D. Anderson & Company (DAC), a global leader in patient recruitment and retention, has been named one of the 50 Largest Women-Owned Businesses in Dallas-Ft. Worth for 2008.
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today reported its operating results for the third quarter and first nine months of 2008.
PAREXEL International Corporation, a global biopharmaceutical services provider, today announced that the Company is among the first to conduct a Chinese bridging study outside of China.
The European Union's efforts in combating rare diseases reached a new milestone this October, with the 50th positive opinion on an 'orphan' medicine being adopted by the EMEA's Committee for Medicinal Products for Human Use (CHMP).
Octagon has released a new process management platform that provides foundation for data, document, and submission management.
Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry, today announced the opening of its new headquarters for its European operations in Zug, Switzerland, near Zurich.
Drug Information Association (DIA) is conducting an event called 9th Conference on European Electronic Document Management which will be held from 03rd December 2008 in Barcelona, Spain.
Drug Information Association (DIA) is conducting an event called European Regulatory Affairs Forum which will be held from 24th November 2008 in Munich, Germany.
Information technology improvements support implementation of enhanced adverse event reporting software.
CEO & Chairman Jim Walker of Octagon Research Solutions, Inc., a provider of breakthrough software and services to the life sciences industry, today announced that Octagon will be exhibiting at the Drug Information Association's (DIA) 7th Annual Electronic Submissions Conference.
Nextrials? Prism wins gold in the mobile star awards for health care data capture technology.
Premier Research achieves double-digit growth in functional sourcing for the third straight year.
CTI upgrades to new releases of remote data entry and adverse event reporting products from Oracle
DSA, a global leader in pharmaceutical safety and pharmacovigilance, announced major hardware and software upgrades to support the implementation of the new Empirica Trace adverse event reporting software.
Industry news focusing on the people and organizations who work in the clinical trials profession.
ACR Image Metrix doubles its initial goal for its first fiscal year.
The latest eClinical software in the clinical trials industry.
The Foundation for Improving Data Quality (FIDQ) advances the evaluation of clinical trial methodologies that aim to improve the clinical integrity and reliability of clinical data.
Finding a global regulatory GPS of ethics committee and competent authority approvals.
The European Parliament's Pediatric Regulation has seen its first approval for a centrally authorized drug to be used in children.
PPD, Inc. today announced the Mario Family Foundation has pledged $5 million to the Rutgers University Ernest Mario School of Pharmacy.